Cyclacel製藥 CYCC 深 滬
已收盤 09-19 16:00:00 美东时间
1.02
-0.025
-2.39%
華盛通- 最 高1.06
- 今 開1.05
- 成交量 2.04万股
- 最 低 0.98
- 昨 收 1.045
- 總市值 134.47万
- 52周最高 11.343
- 市盈率 靜 --
- 換手率 1.55%
- 52周最低 0.9517
- 委 比 -38.43%
- 總股本 131.83万
- 歷史最高 29448.00
- 量 比 0.91
- 振 幅 7.66%
- 歷史最低 0.9517
- 每 手 1
- 風險率 2.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | Cyclacel Pharmaceuticals：决议通过，暂停每季度兑换型可转换优先股票的现金股息支付，预计于11月1日
Cyclacel Pharmaceuticals: Passed Resolution to Suspend Qtrly Cash Dividend Paym...
09-07 04:07
Cyclacel files an appeal to Nasdaq delisting letter
Biopharma company Cyclacel Pharmaceuticals (NASDAQ:CYCC) said on Tuesday it has filed an appeal to Nasdaq’s delisting letter and requested a hearing, which has been scheduled for October 15. The reque...
09-03 21:48
Cyclacel Pharmaceuticals GAAP EPS of -$0.72
Cyclacel Pharmaceuticals press release (NASDAQ:CYCC): Q2 GAAP EPS of -$0.72. Revenue of $4,000 (vs. $373K in Q2/2023). As of June 30, 2024, cash equivalents totaled $6M, compared to $3.4M as of Decemb...
08-15 20:55
快讯 | cyclacel pharmaceuticals, inc.现有的现金资源将为计划中的项目提供资金，直至2024年第四季度。
Cyclacel Pharmaceuticals Inc - Current Cash Resources Will Fund Planned Program...
08-15 04:09
快讯 | Cyclacel pharmaceuticals：收到欧洲专利局意向通知，涵盖Plogosertib药品组成的专利即将授权。
Cyclacel Pharmaceuticals: Got Notice From European Patent Office of Intention t...
06-26 21:21
Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual Meeting
Cyclacel Pharmaceuticals (CYCC) has shared an announcement. During Cyclacel Pha...
06-25 18:29
快讯 | Cyclacel Pharmaceuticals：Fadraciclib在2024年ASCO年会上展示了在患者源性结直肠癌模型中的功效。
Cyclacel Pharmaceuticals：Fadraciclib在2024年ASCO年会上展示了在患者源性结直肠癌模型中的功效。
06-04 07:08
快讯 | Cyclacel Pharmaceuticals：fadraciclib在2024年ASCO年会上展示出对患者衍生的结肠癌模型的疗效。
Cyclacel Pharmaceuticals: Fadraciclib Demonstrates Efficacy in Patient-Derived ...
06-04 07:06
Notable earnings after Tuesday's close
Major earnings expected after the bell on Tuesday include: Oxford Lane Capital Corp. (OXLC) Capital Southwest Corporation (CSWC) Seadrill Limited (SDRL) Nu Holdings Ltd. (NU) Canoo (GOEV) Other earnin...
05-14 05:35
Cyclacel Pharmaceuticals files to sell 15.2M shares for holders
Cyclacel Pharmaceuticals (NASDAQ:CYCC) on Monday filed a prospectus related to a proposed resale of about 15.2M shares of its common stock by selling stockholders. This prospectus is not an offer to s...
05-07 05:54
